Get the app
US › Healthcare

BGM Group Ltd. (BGM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$8.25-8.33%
Last close · 2026-11-06

Latest quarter · ended 2026-03-31

Revenue
$24.3M
Net profit
$-2.1M
Net margin
-8.7%

Key statistics

Market cap
$127.4M
Forward P/E
0.0
P/B
0.33
Book value
$59.55
EPS (TTM)
$-4.80
52-week high
$291.30
52-week low
$6.45
50-day MA
$8.58
200-day MA
$18.21
Beta
1.46

Shareholding

Insiders
38.05%
Institutions
0.10%

Largest institutional holders

FundStake
Geode Capital Management, LLC0.02%
XTX Topco Ltd0.02%
UBS Group AG0.01%
Jane Street Group LLC0.01%
Virtu Financial LLC0.01%
Susquehanna International Group, LLP0.01%
Ground Swell Capital, LLC0.00%
JPMorgan Chase & Co0.00%

Corporate actions

ActionDetailDate
Split1 : 30
effective Oct 1, 2026		2026-10-01

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for BGM Group Ltd. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.